Lv0
0 积分 2024-01-16 加入
Lupus Nephritis
5小时前
待确认
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
3天前
已完结
The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience
10天前
已完结
The Pharmacoeconomic Analysis of Cetuximab and Panitumumab in the 1st Line Treatment of mCRC in Real Clinical Practice in the Czech Republic
1个月前
已完结
Current advances in targeted therapy for metastatic colorectal cancer – Clinical translation and future directions
1个月前
已完结
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
1个月前
已完结
Colorectal cancer: A health and economic problem
1个月前
已完结
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
1个月前
已完结
A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
2个月前
已完结
Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients
3个月前
已完结
皖公网安备34019202002308
